Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21693267rdf:typepubmed:Citationlld:pubmed
pubmed-article:21693267lifeskim:mentionsumls-concept:C0376387lld:lifeskim
pubmed-article:21693267lifeskim:mentionsumls-concept:C0348050lld:lifeskim
pubmed-article:21693267lifeskim:mentionsumls-concept:C0023911lld:lifeskim
pubmed-article:21693267lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:21693267lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:21693267pubmed:issue5lld:pubmed
pubmed-article:21693267pubmed:dateCreated2011-6-22lld:pubmed
pubmed-article:21693267pubmed:abstractTextAdult-to-adult living donor liver transplantation (A-A LDLT) is an effective therapeutic modality to treat patients with end-stage liver disease. The aims of this study were to identify recipient characteristics of A-A LDLT seeking to determine variables that affected patient survival. We retrospectively examined a cohort of 154 consecutive A-A LDLT recipients with end-stage liver disease in our center over 4 years. All donors volunteered to give their partial livers with written consent. There were no organs from prisoners and no prisoner subjects. The overall survivals at 1, 2, 3, 6, 12, 24, 36, and 48 months were 93.5%, 90.9%, 88.9%, 86.3%, 80%, 65.6%, 63.8%, and 63.8%, respectively. About 31 pre- and intraoperative factors were analyzed to identify correlations with posttransplant survival using the Cox proportional-hazards regression model. Recipient age, serum creatinine concentration, intraoperative blood loss, and graft-to-recipient weight ratio were significant predictors of survival after transplantation. The prognostic index model, which was calculated by combining these four prognostic values with their regression coefficients, showed a c-statistic of 0.706 (95% confidence interval [CI] = 0.621-0.792) compared with the Model for End-stage Liver Disease value of 0.546 (95% CI = 0.350-0.558). There was a significant difference between the predictions achieved with the two models (P = .012). In conclusion, selecting younger recipients, better pretransplant renal condition, reduced intraoperative blood loss, and graft-to-recipient size match appeared to be advantageous to achieve better survivals among patients undergoing A-A LDLT.lld:pubmed
pubmed-article:21693267pubmed:languageenglld:pubmed
pubmed-article:21693267pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21693267pubmed:citationSubsetIMlld:pubmed
pubmed-article:21693267pubmed:statusMEDLINElld:pubmed
pubmed-article:21693267pubmed:monthJunlld:pubmed
pubmed-article:21693267pubmed:issn1873-2623lld:pubmed
pubmed-article:21693267pubmed:authorpubmed-author:LamY KYKlld:pubmed
pubmed-article:21693267pubmed:authorpubmed-author:YuanDDlld:pubmed
pubmed-article:21693267pubmed:authorpubmed-author:ZenzJJlld:pubmed
pubmed-article:21693267pubmed:authorpubmed-author:MICClld:pubmed
pubmed-article:21693267pubmed:authorpubmed-author:ZhaoJ CJClld:pubmed
pubmed-article:21693267pubmed:authorpubmed-author:ChenZ YZYlld:pubmed
pubmed-article:21693267pubmed:authorpubmed-author:XuNNlld:pubmed
pubmed-article:21693267pubmed:authorpubmed-author:WangW TWTlld:pubmed
pubmed-article:21693267pubmed:authorpubmed-author:YangJ YJYlld:pubmed
pubmed-article:21693267pubmed:authorpubmed-author:XuM QMQlld:pubmed
pubmed-article:21693267pubmed:authorpubmed-author:JinS GSGlld:pubmed
pubmed-article:21693267pubmed:authorpubmed-author:WenT FTFlld:pubmed
pubmed-article:21693267pubmed:copyrightInfoCopyright © 2011. Published by Elsevier Inc.lld:pubmed
pubmed-article:21693267pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21693267pubmed:volume43lld:pubmed
pubmed-article:21693267pubmed:ownerNLMlld:pubmed
pubmed-article:21693267pubmed:authorsCompleteYlld:pubmed
pubmed-article:21693267pubmed:pagination1728-35lld:pubmed
pubmed-article:21693267pubmed:meshHeadingpubmed-meshheading:21693267...lld:pubmed
pubmed-article:21693267pubmed:meshHeadingpubmed-meshheading:21693267...lld:pubmed
pubmed-article:21693267pubmed:meshHeadingpubmed-meshheading:21693267...lld:pubmed
pubmed-article:21693267pubmed:meshHeadingpubmed-meshheading:21693267...lld:pubmed
pubmed-article:21693267pubmed:meshHeadingpubmed-meshheading:21693267...lld:pubmed
pubmed-article:21693267pubmed:meshHeadingpubmed-meshheading:21693267...lld:pubmed
pubmed-article:21693267pubmed:meshHeadingpubmed-meshheading:21693267...lld:pubmed
pubmed-article:21693267pubmed:meshHeadingpubmed-meshheading:21693267...lld:pubmed
pubmed-article:21693267pubmed:meshHeadingpubmed-meshheading:21693267...lld:pubmed
pubmed-article:21693267pubmed:meshHeadingpubmed-meshheading:21693267...lld:pubmed
pubmed-article:21693267pubmed:meshHeadingpubmed-meshheading:21693267...lld:pubmed
pubmed-article:21693267pubmed:meshHeadingpubmed-meshheading:21693267...lld:pubmed
pubmed-article:21693267pubmed:year2011lld:pubmed
pubmed-article:21693267pubmed:articleTitleNew prognostic model for adult-to-adult living donor liver transplant recipients.lld:pubmed
pubmed-article:21693267pubmed:affiliationDepartment of Liver and Vascular Surgery & West China Liver Transplant Center, West China Hospital, Sichuan University, Chengdu, China.lld:pubmed
pubmed-article:21693267pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21693267pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed